RESERPINE AND HYDROCHLOROTHIAZIDE-50 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Reserpine And Hydrochlorothiazide-50, and what generic alternatives are available?
Reserpine And Hydrochlorothiazide-50 is a drug marketed by West Ward and is included in one NDA.
The generic ingredient in RESERPINE AND HYDROCHLOROTHIAZIDE-50 is hydrochlorothiazide; reserpine. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; reserpine profile page.
Summary for RESERPINE AND HYDROCHLOROTHIAZIDE-50
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 84 |
Clinical Trials: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | RESERPINE AND HYDROCHLOROTHIAZIDE-50 at DailyMed |
Recent Clinical Trials for RESERPINE AND HYDROCHLOROTHIAZIDE-50
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
West China Hospital | Phase 4 |
US Department of Veterans Affairs | |
VA Office of Research and Development |
See all RESERPINE AND HYDROCHLOROTHIAZIDE-50 clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for RESERPINE AND HYDROCHLOROTHIAZIDE-50
US Patents and Regulatory Information for RESERPINE AND HYDROCHLOROTHIAZIDE-50
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
West Ward | RESERPINE AND HYDROCHLOROTHIAZIDE-50 | hydrochlorothiazide; reserpine | TABLET;ORAL | 088189-001 | May 10, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |